Disease: Progressive multifocal leukoencephalopathy
- (18)F-THK5351 Positron Emission Tomography Clearly Depicted Progressive Multifocal Leukoencephalopathy after Mantle Cell Lymphoma Treatment
- <sup>18</sup>F-THK5351 Positron Emission Tomography Clearly Depicted Progressive Multifocal Leukoencephalopathy After Mantle Cell Lymphoma Treatment
- "One a penny, two a penny", I saw the hot cross bun sign"
- "Shrimp Sign" in Progressive Multifocal Leukoencephalopathy
- A case of a cerebellar form of progressive multifocal leukoencephalopathy in a patient undergoing peritoneal dialysis
- A case report of a lung transplant recipient receiving belatacept in combination with low dose tacrolimus complicated by progressive multifocal leukoencephalopathy
- A pharmacovigilance study on antibody-drug conjugate (ADC)-related neurotoxicity based on the FDA adverse event reporting system (FAERS)
- A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy
- Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serum
- Advances in diffuse glioma assessment: preoperative and postoperative applications of chemical exchange saturation transfer
- Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab
- Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification
- Atypical Presentation of a Patient With Progressive Multifocal Leukoencephalopathy
- Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials
- Capecitabine-Related Fourth Nerve Palsy: A Case Report
- Case report and literature review of AIDS-related progressive multifocal leukoencephalopathy diagnosed in a psychiatric department
- Cerebellar progressive multifocal leucoencephalopathy identified by the shrimp sign
- Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder
- Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy
- Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design
- Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis
- Clinical profile of central nervous system space-occupying lesions and their association with CD4 counts in patients with HIV: A prospective observational study
- Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report
- Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma
- Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis
- Differentiation of highly pathogenic strains of human JC polyomavirus in neurological patients by next generation sequencing
- Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis
- Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- Exploring JC polyomavirus sequences and human gene expression in brain tissue of patients with progressive multifocal leukoencephalopathy
- Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
- Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
- Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient
- Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy
- Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies
- Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19: a case report
- High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection
- Hot cross bun sign in JC-Virus Granule cell neuronopathy in HIV infected patient - a case report
- Hydroxychloroquine can be resumed with close monitoring after retinopathy has developed, without major visual loss: Case Report
- I saw the "shrimp sign": Cerebellar progressive multifocal leukoencephalopathy
- Inflammatory progressive multifocal leukoencephalopathy with human T-cell lymphotropic virus-1 coinfection
- Insights into the genetic characteristics, clustering patterns, and phylogeographic dynamics of the JC polyomavirus, 1993 to 2023
- Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentration
- Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
- JC virus spread is potentiated by glial replication and demyelination-linked glial proliferation
- JCPyV infection of primary choroid plexus epithelial cells reduces expression of critical junctional proteins and increases expression of barrier disrupting inflammatory cytokines
- JCV granule cell neuronopathy: A rare case manifestation
- John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis
- Leukoencephalopathy with calcifications, developmental brain abnormalities and skeletal dysplasia due to homozygosity for a hypomorphic CSF1R variant: A report of three siblings
- Natalizumab
- Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres
- Neurosarcoidosis as a rapidly progressive dementia associated with normal pressure hydrocephalus
- Ocrelizumab-induced organizing pneumonia in multiple sclerosis: case report and literature review
- Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
- Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study
- Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study
- Primary central nervous system lymphoma: Imaging features and differential diagnosis
- Progressive multifocal leucoencephalopathy isolated to the brainstem and cerebellum
- Progressive Multifocal Leukoencephalopathy
- Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report database
- Progressive multifocal leukoencephalopathy and spectrum of predisposing conditions: a 20-year retrospective cohort study in a tertiary center in Sao Paulo, Brazil
- Progressive multifocal leukoencephalopathy as the presenting feature in a patient with occult low-count monoclonal B-cell lymphocytosis
- Progressive multifocal leukoencephalopathy associated with rituximab treatment
- Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging
- Progressive multifocal leukoencephalopathy following obinutuzumab and bendamustine therapy for follicular lymphoma: case report and literature review
- Progressive multifocal leukoencephalopathy in a lung transplant recipient
- Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report
- Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication
- Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report
- Progressive multifocal leukoencephalopathy in children with HIV: still a challenge
- Progressive Multifocal Leukoencephalopathy in Myasthenia Gravis With Selective Hypogammaglobulinemia
- Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab
- Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab
- Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
- Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab
- Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient
- Progressive multifocal leukoencephalopathy with a benign prognosis in an immunocompetent patient - A case report
- Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
- Pure alexia in progressive multifocal leukoencephalopathy after COVID-19
- Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study
- Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis
- Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases
- Safety and effectiveness of disease-modifying therapies after switching from natalizumab
- Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis
- Spinal cord involvement in progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome
- Spongiform leukoencephalopathy unveiled in an autopsy of a drug abuser
- Structural vaccinology, molecular simulation and immune simulation approaches to design multi-epitopes vaccine against John Cunningham virus
- Successful BK virus-specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy
- SUCCESSFUL BK VIRUS-SPECIFIC T CELLS THERAPY IN A KIDNEY TRANSPLANT RECIPIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
- Surrogate endpoints for progressive multifocal leukoencephalopathy
- Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era
- Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review
- The 504th case: Multiple lymph node enlargement, renal insufficiency, blindness, and white matter lesions of the brain
- The Connecting Link: A Case Report of the First Association of COVID-19 and Progressive Multifocal Leukoencephalopathy
- The history of the Japanese Society for Neuro-infectious Diseases: Foundation, objectives, and legacy
- The impact of social distancing measures on anti-JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis
- Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine
- Unusual demyelinating disease in a patient with HIV infection
- Unveiling the Enigma: John Cunningham Virus-Associated Progressive Multifocal Leukoencephalopathy in an Immunocompetent Individual
- Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations
- Varicella Zoster Associated Vasculopathy and Retinitis with Natalizumab Use in Multiple Sclerosis